findmyKOL

Jimmy Ma, MD

Basic profile

University of Washington

ORCIDNPI
RegionSeattle, WA · WestSpecialtyInfectious DiseaseFocusInfectious Disease
ActivityNot yet indexedEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Jimmy Ma is an Infectious Disease physician affiliated with University of Washington. OpenAlex indexes 53 publications with 278 citations (h-index 8).

Overview

Scholarship

indexed output and impact (OpenAlex)
53publications

Distinct works indexed by OpenAlex, matched via ORCID.

278citations

Total citations across indexed works.

8h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    36.4%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor23.8%
    Tivicay100%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor12.6%
    Descovy100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    26.5%
    H2 blocker9.3%
    Famotidine100%
    Part D<11 patients
    Opioid Antagonist8.6%
    Naloxone Hcl100%
    Part D11 patients

    + 1 more class in this area

  • Cardiovascular

    17.2%
    Calcium channel blocker9.9%
    Amlodipine Besylate100%
    Part D<11 patients
    Loop diuretic7.3%
    Torsemide100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”